Drawing for PICOVIR

USPTO serial 87023159

PICOVIR

Reviewed by CopyMark Law Group

Reg. 6119173Status 700Renewal
Filing date
Status date
Registration date
Aug 4, 2020
Examiner
FATHY, DOMINIC
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PICOVIR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $425

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sima Singadia Kulkarni

Sima Singadia Kulkarni DLA Piper LLP (US)1650 Market StreetSuite 5000Philadelphia, PA 19103

Goods and services

ClassDescriptionStatusFirst use
005Antivirals, Pharmaceutical preparations for the treatment of infectious diseases, Pharmaceutical preparations for the treatment and prevention of infectious diseases, Pharmaceutical preparations for the treatment of sepsis, Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders, Pharmaceutical preparations, namely, antivirals, Pharmaceutical preparations for the treatment of picornavirus, enterovirus, rhinovirus infection, Pharmaceutical preparations for the treatment of neonatal enteroviral sepsisACTIVEOct 31, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 4, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 4, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 30, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jun 29, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jun 10, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jun 8, 2020IUAFUSE AMENDMENT FILED—
Jun 8, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 6, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 5, 2019EX5GSOU EXTENSION 5 GRANTED—
Dec 5, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 3, 2019EXT5SOU EXTENSION 5 FILED—
Dec 3, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 4, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 31, 2019EX4GSOU EXTENSION 4 GRANTED—
May 31, 2019EXT4SOU EXTENSION 4 FILED—
May 31, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 8, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 6, 2018EX3GSOU EXTENSION 3 GRANTED—
Dec 6, 2018EXT3SOU EXTENSION 3 FILED—
Dec 6, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 31, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 29, 2018EX2GSOU EXTENSION 2 GRANTED—
May 29, 2018EXT2SOU EXTENSION 2 FILED—
May 29, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 7, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 5, 2017EX1GSOU EXTENSION 1 GRANTED—
Dec 5, 2017EXT1SOU EXTENSION 1 FILED—
Dec 5, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 26, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 26, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 6, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 27, 2017ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Nov 4, 2016ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Oct 18, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 18, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 28, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 22, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 22, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Aug 22, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 22, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 22, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 20, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 20, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 20, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 18, 2016DOCKASSIGNED TO EXAMINER—
May 6, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 6, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance